No Data
No Data
ADRs End Lower; Opthea Ltd. Declines 22%
This article was automatically generated by Dow Jones using technology from Automated Insights. International stocks trading in New York closed lower on Friday, as the S&P/BNY Mellon index of America
Opthea Raises AU$171.5 Million via Institutional Placement, Offer; Shares Down 23%
Clinical-stage biopharmaceutical company Opthea (ASX:OPT) raised AU$171.5 million from a recently completed institutional placement and entitlement offer, according to a Friday filing with the Austral
Opthea Completes Enrollments in COAST, ShORe Trials
Clinical-stage biopharmaceutical company Opthea (ASX:OPT) has completed enrollment in its COAST and ShORe trials that comprise its Phase 3 clinical program, according to a Tuesday Australian bourse fi
Express News | Watching Protara Therapeutics, Opthea Ltd.; Shares Moving Higher As Traders Circulate Post From 'TipRanks' Suggesting "These 2 'Strong Buy' Penny Stocks Could Surge Over 400%, Says Oppenheimer"
Owning 39% Shares,institutional Owners Seem Interested in Opthea Limited (ASX:OPT),
Press Release: Opthea Appoints Sujal Shah to the Board of Directors
Opthea Appoints Sujal Shah to the Board of Directors Former CymaBay Therapeutics CEO brings extensive leadership experience to his role as a Non-Executive Director and Audit and Risk Committee Chair
No Data